Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update
Julia Bohlius(University of Bern), Alejandro Lazo‐Langner(Western University), Benjamin Djulbegović(University of South Florida), Roberto Castelli(University of Milan), Giannis Mountzios(Henry Dunant Hospital), Gianluca Trifirò(University of Verona), Laura Porter(Georgetown University), Massimo Martino(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Namrata Peswani(Advocate Health Care), Maryam B. Lustberg(Yale Cancer Center), Kari Bohlke, Hushan Yang(Thomas Jefferson University), Tiffany Tanaka(UC San Diego Health System)
Cited by 165
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*
|Annals of Internal Medicine|2012|1.1k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline
|Journal of Clinical Oncology|2022|608